Woodmont Investment Counsel LLC grew its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 0.3% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 83,880 shares of the company’s stock after buying an additional 268 shares during the quarter. Procter & Gamble comprises approximately 1.1% of Woodmont Investment Counsel LLC’s portfolio, making the stock its 20th largest holding. Woodmont Investment Counsel LLC’s holdings in Procter & Gamble were worth $13,609,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Advantage Trust Co acquired a new stake in Procter & Gamble in the fourth quarter worth about $28,000. Naples Money Management LLC acquired a new stake in Procter & Gamble in the fourth quarter worth about $29,000. Wyrmwood Management LLC acquired a new stake in Procter & Gamble in the fourth quarter worth about $29,000. Transcendent Capital Group LLC acquired a new stake in Procter & Gamble in the fourth quarter worth about $31,000. Finally, MeadowBrook Investment Advisors LLC acquired a new stake in Procter & Gamble in the fourth quarter worth about $33,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, CEO Sundar G. Raman sold 31,924 shares of the company’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the completion of the sale, the chief executive officer now directly owns 19,042 shares in the company, valued at approximately $3,179,061.90. The sale was disclosed in a filing with the SEC, which is available through this link. In other Procter & Gamble news, COO Shailesh Jejurikar sold 31,859 shares of the company’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $164.90, for a total value of $5,253,549.10. Following the completion of the transaction, the chief operating officer now owns 9,739 shares of the company’s stock, valued at approximately $1,605,961.10. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Sundar G. Raman sold 31,924 shares of the company’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the completion of the transaction, the chief executive officer now directly owns 19,042 shares of the company’s stock, valued at approximately $3,179,061.90. The disclosure for this sale can be found here. In the last three months, insiders sold 154,544 shares of company stock worth $25,413,051. 0.17% of the stock is currently owned by company insiders.
Procter & Gamble Stock Up 0.7 %
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.10. The business had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm’s quarterly revenue was up .6% on a year-over-year basis. During the same period in the previous year, the company posted $1.37 EPS. Equities research analysts expect that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.46%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date was Thursday, April 18th. Procter & Gamble’s dividend payout ratio is presently 65.85%.
Analyst Ratings Changes
A number of analysts recently commented on PG shares. Truist Financial upgraded Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. BNP Paribas started coverage on Procter & Gamble in a report on Monday, June 24th. They set an “outperform” rating and a $187.00 target price on the stock. Barclays raised their target price on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a report on Tuesday, April 23rd. Argus raised their target price on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Finally, Jefferies Financial Group lifted their price objective on Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a report on Monday, April 22nd. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $170.72.
Get Our Latest Stock Report on PG
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Read More
- Five stocks we like better than Procter & Gamble
- Health Care Stocks Explained: Why You Might Want to Invest
- RXO Shares Surge Following New Acquisition Deal
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Conference Calls and Individual Investors
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.